(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZILBRYSQ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

ZILBRYSQ

ST13

US500000098179729

Class

5, 10

Filing

98179729

Registration

7673264

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

33

Latest update

02/24/2025

Trademark type

Word

Nice classes

5, 10

Filing date

09/14/2023

Registration date

01/28/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/28/2025

Last transaction

02/24/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

01/03/2024

First use in commerce

01/03/2024

Drawing code

4

Owner type

03

Owner location

SMYRNA, GA

Examiner

GRAJEDA, HECTOR

Law office

N50

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

UCB HOLDINGS, INC.
Ra Pharmaceuticals, Inc.

Representatives

Kumiko Ide WENDEROTH, LIND & PONACK, L.L.P.

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical preparationsfor human usefor the prevention and treatment of myasthenia gravis

Class 10

Syringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparationsfor human usefor the prevention and treatment of paroxysmal nocturnal hemoglobinuriamyasthenia gravisan inflammatory indicationa wounda burnan autoimmune indicationa pulmonary indicationa cardiovascular indicationa neurological indicationa kidney-related indicationa diabetes-related indicationan ocular indicationa pregnancy-related indication

Publications

History of USPTO decisions and trademark events.

33 publications found

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

02/24/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/28/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

01/28/2025

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/06/2025

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/06/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

11/26/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/26/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

11/25/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

11/14/2024

GNRT

NON-FINAL ACTION E-MAILED

11/14/2024

CNRT

SU - NON-FINAL ACTION - WRITTEN

11/14/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

10/29/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

10/29/2024

IUAF

USE AMENDMENT FILED

08/27/2024

EISU

TEAS STATEMENT OF USE RECEIVED

08/27/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

08/13/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

06/18/2024

PUBO

PUBLISHED FOR OPPOSITION

06/18/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

05/29/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

05/13/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/10/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/10/2024

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

05/10/2024

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/08/2024

GNRT

NON-FINAL ACTION E-MAILED

05/08/2024

CNRT

NON-FINAL ACTION WRITTEN

05/08/2024

DOCK

ASSIGNED TO EXAMINER

05/08/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/30/2024

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/30/2024

ALIE

ASSIGNED TO LIE

04/30/2024

PARI

TEAS VOLUNTARY AMENDMENT RECEIVED

12/08/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/03/2023

NWAP

NEW APPLICATION ENTERED

09/18/2023

Continuous trademark protection

Get notified about every new filing that threatens ZILBRYSQ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.